Home › Therapeutic areas › Metabolic › Pompe Disease
Pompe Disease (3 companies)
Companies with an active program in Pompe Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics | MetabolicNeurology Rare | 1 | NDA Submitted | $3.39B | 10 |
| FBIO | Fortress Biotech | DermatologyHematology+3 Rare | 1 | Approved | $61.7M | 12 |
| MAZE | Maze Therapeutics | MetabolicRenal Rare | 1 | Phase 2 | $1.90B | 4 |
No companies match.